Search Results - S. Piha-Paul

Refine Results
  1. 1
    A non-pregnant woman with elevated beta-HCG: A case of para-neoplastic syndrome in ovarian cancer

    A non-pregnant woman with elevated beta-HCG: A case of para-neoplastic syndrome in ovarian cancer by Goldstein, Jennifer, Pandey, Prasamsa, Fleming, Nicole, Westin, Shannon, Piha-Paul, Sarina

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    The “Shield Sign” in Two Men with Metastatic Salivary Duct Carcinoma to the Skin: Cutaneous Metastases Presenting as Carcinoma Hemorrhagiectoides

    The “Shield Sign” in Two Men with Metastatic Salivary Duct Carcinoma to the Skin: Cutaneous Metastases Presenting as Carcinoma Hemorrhagiectoides by Cohen, Philip R., Prieto, Victor G., Piha-Paul, Sarina A., Kurzrock, Razelle

    Published 2012
    Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Photoallergic reaction in a patient receiving vandetanib for metastatic follicular thyroid carcinoma: a case report

    Photoallergic reaction in a patient receiving vandetanib for metastatic follicular thyroid carcinoma: a case report by Goldstein, Jennifer, Patel, Anisha B., Curry, Jonathan L., Subbiah, Vivek, Piha-Paul, Sarina

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRXL301, a nanoparticle of docetaxel

    Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRXL301... by Mukhtar, Eiman, Worroll, Daniel, Galletti, Giuseppe, Schuster, Shelly, Piha-Paul, Sarina A., Giannakakou, Paraskevi

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Safety and Antitumor Activity of the Anti–Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma

    Safety and Antitumor Activity of the Anti–Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma by Toshihiko Doi, Sarina A. Piha‐Paul, Shadia I. Jalal, Sanatan Saraf, Jared Lunceford, Minori Koshiji, Jaafar Bennouna

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Biomarker-Directed Therapy of Squamous Carcinomas of the Head and Neck: Targeting PI3K/PTEN/mTOR Pathway

    Biomarker-Directed Therapy of Squamous Carcinomas of the Head and Neck: Targeting PI3K/PTEN/mTOR Pathway by Holsinger, Floyd Christopher, Piha-Paul, Sarina Anne, Janku, Filip, Hong, David S., Atkins, Johnique T., Tsimberidou, Apostolia M., Kurzrock, Razelle

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    A mutation-specific, single-arm, phase 2 study of dovitinib in patients with advanced malignancies

    A mutation-specific, single-arm, phase 2 study of dovitinib in patients with advanced malignancies by Taylor, Matthew H., Alva, Ajjai S., Larson, Timothy, Szpakowski, Sebastian, Purkaystha, Das, Amin, Alpesh, Karpiak, Linda, Piha-Paul, Sarina A.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Pediatric Patients with Refractory Central Nervous System Tumors: Experiences of a Clinical Trial Combining Bevacizumab and Temsirolimus

    Pediatric Patients with Refractory Central Nervous System Tumors: Experiences of a Clinical Trial Combining Bevacizumab and Temsirolimus by Piha-Paul, Sarina A., Shin, Sang Joon, Vats, Tribhawan, Guha-Thakurta, Nandita, Aaron, Joann, Rytting, Michael, Kleinerman, Eugenie, Kurzrock, Razelle

    Published 2014
    Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors

    Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors by Mita, Monica, Fu, Siqing, Piha-Paul, Sarina Anne, Janku, Filip, Mita, Alain, Natale, Ronald, Guo, Wei, Zhao, Charles, Kurzrock, Razelle, Naing, Aung

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumours

    Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumours by Sarina A. Piha‐Paul, P.N. Munster, Antoine Hollebecque, Guillem Argilés, Olav Dajani, Joyce Cheng, Ran Wang, A. Swift, Alessandra Tosolini, Shiva Gupta

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumors

    Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumors by Piha-Paul, S.A., Munster, P.N., Hollebecque, A., Argilés, G., Dajani, O., Cheng, J.D., Wang, R., Swift, A., Tosolini, A., Gupta., S.

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial

    Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial by How, Jeffrey A., Jazaeri, Amir A., Soliman, Pamela T., Fleming, Nicole D., Gong, Jing, Piha-Paul, Sarina A., Janku, Filip, Stephen, Bettzy, Naing, Aung

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer

    Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer by Funda Meric‐Bernstam, Amber M. Johnson, Ecaterina E. Dumbrava, Kanwal Raghav, Kavitha Balaji, Michelle Bhatt, Rashmi K. Murthy, Jordi Rodón, Sarina A. Piha‐Paul

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus

    Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus by Piha-Paul, Sarina A., Wheler, Jennifer J., Fu, Siqing, Levenback, Charles, Lu, Karen, Falchook, Gerald S., Naing, Aung, Hong, David S., Tsimberidou, Apostolia M., Kurzrock, Razelle

    Published 2014
    Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Survival of 1,181 Patients in a Phase I Clinic: The MD Anderson Clinical Center for Targeted Therapy Experience

    Survival of 1,181 Patients in a Phase I Clinic: The MD Anderson Clinical Center for Targeted Therapy Experience by Wheler, Jennifer, Tsimberidou, Apostolia M., Hong, David, Naing, Aung, Falchook, Gerald, Piha-Paul, Sarina, Fu, Siqing, Moulder, Stacy, Stephen, Bettzy, Wen, Sijin, Kurzrock, Razelle

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    The Effect of Renal Impairment on the Pharmacokinetics and Safety of Talazoparib in Patients with Advanced Solid Tumors

    The Effect of Renal Impairment on the Pharmacokinetics and Safety of Talazoparib in Patients with Advanced Solid Tumors by Durairaj, Chandrasekar, Chakrabarti, Jayeta, Ferrario, Cristiano, Hirte, Holger W., Babu, Sunil, Piha-Paul, Sarina A., Plotka, Anna, Hoffman, Justin, Shi, Haihong, Wang, Diane D.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Evaluation of pharmacokinetics and safety of talazoparib in patients with advanced cancer and varying degrees of hepatic impairment

    Evaluation of pharmacokinetics and safety of talazoparib in patients with advanced cancer and varying degrees of hepatic impairment by Guo, Cen, Yu, Yanke, Chakrabarti, Jayeta, Piha‐Paul, Sarina A., Moroose, Rebecca, Plotka, Anna, Shi, Haihong, Durairaj, Chandrasekar, Wang, Diane D., Wainberg, Zev A.

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Aberrations in the epidermal growth factor receptor gene in 958 patients with diverse advanced tumors: implications for therapy

    Aberrations in the epidermal growth factor receptor gene in 958 patients with diverse advanced tumors: implications for therapy by Wheler, J. J., Falchook, G. S., Tsimberidou, A. M., Hong, D. S., Naing, A., Piha-Paul, S. A., Chen, S. S., Fu, S., Stephen, B., Fok, J. Y., Janku, F., Kurzrock, R.

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Combining Erlotinib and Cetuximab is Associated with Activity in Patients with Non Small Cell Lung Cancer (including Squamous Cell Carcinomas) and Wild-Type EGFR or Resistant Mutations

    Combining Erlotinib and Cetuximab is Associated with Activity in Patients with Non Small Cell Lung Cancer (including Squamous Cell Carcinomas) and Wild-Type EGFR or Resistant Mutat... by Wheler, Jennifer J., Tsimberidou, Apostolia M., Falchook, Gerald S., Zinner, Ralph G., Hong, David S., Fok, Jansina Y., Fu, Siqing, Piha-Paul, Sarina A., Naing, Aung, Kurzrock, Razelle

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer

    Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer by Meric-Bernstam, Funda, Johnson, Amber M., Dumbrava, Ecaterina E. Ileana, Raghav, Kanwal P., Balaji, Kavitha, Bhatt, Michelle, Murthy, Rashmi K., Rodon, Jordi, Piha-Paul, Sarina A.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: